Shin Nippon Biomedical Laboratories (TSE:2395) Quality Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:2395 Shin Nippon Biomedical Laboratories Ltd TSE:2395
78 GF Score
Price 円1,471.00
GF Value 円1,808.04
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Shin Nippon Biomedical Laboratories Quality Rank?

The Quality Rank measures the business quality of a company relative to other companies. It is ranked based on the strength of the balance sheet, as well as the profitability and growth of the business. The ranked companies are split in equal numbers and then ranked from 1 to 10, with 10 being the highest.

The rank of balance sheet (30%)

The rank of balance sheet is done through the ranking of:
  • Interest coverage
  • Zscore
  • Debt to revenue
  • Equity to asset
  • Cash to debt

The rank of Profitability (70%)

The ranking of Profitability is done by ranking:
  • Operating margin mean rank (10-year mean average profit margine)
  • Operating margin growth rank
  • Fscore
  • Predictability rank
  • Revenue growth rank (5 year), when the growth is higher than 25%, set it as 25%
  • Num of year profit (number of years that is profitable within the last 10 years)
  • ROIC median (10-year median of ROIC)

Shin Nippon Biomedical Laboratories Quality Rank Related Terms

TSE:2395
78GF Score
Shin Nippon Biomedical Laboratories Ltd TSE:2395
Quality Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Shin Nippon Biomedical Laboratories (TSE:2395) Overvalued in 2026?

Based on GuruFocus' analysis, Shin Nippon Biomedical Laboratories stock appears to be undervalued. The current stock price of 円1,471.00 is trading 18.6% below its estimated GF Value™ of 円1,808.04. GuruFocus considers Shin Nippon Biomedical Laboratories to be Modestly Undervalued.

Key valuation signals for TSE:2395:

  • Quality Rank:
  • GF Value™: 円1,808.04 vs. price of 円1,471.00 (18.6% below fair value)
  • GF Score™: 78/100 with 5 warning signs

No single metric tells the full story. See the TSE:2395 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shin Nippon Biomedical Laboratories Business Description

Other Exchanges YB3:Germany
Address 8-1 Akashi-cho, Tokyo, JPN
Shin Nippon Biomedical Laboratories Ltd provides pre-clinical testing services in the pharmaceutical industry in Japan. The company provides a range of services such as pre-clinical and analysis studies, contracted clinical trials, SMO, CRO, translational research and cancer treatment.
78GF Score

Get the complete analysis for TSE:2395

Quality Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,471.00
Price
円1,808.04
GF Value